As biologics, sterile injectables and advanced manufacturing gain ground across the region, HVAC is becoming less of a utility and more of a critical part of facility design.
Southeast Asia is attracting a different kind of pharmaceutical investment.
Singapore is adding next-generation biopharma capacity, including AstraZeneca’s US$1.5 billion antibody-drug conjugate facility. Malaysia is expanding into insulin, monoclonal antibodies, recombinant proteins and sterile injectables. Vietnam and Thailand are also attracting new pharmaceutical manufacturing investments.
The interesting part isn’t just the scale of investment.
It’s what these facilities demand.
More sophisticated products mean tighter control over temperature, humidity, pressure, filtration, contamination and airflow.
And that puts HVAC much closer to the manufacturing process itself.
A sterile injectable facility cannot treat HVAC as an afterthought.
A biologics plant cannot separate environmental control from process design.
And a modern GMP facility increasingly has to balance compliance, reliability and energy performance at the same time.
That is changing the conversation from:
“What HVAC system do we need?”
to:
“What environmental-control architecture does this manufacturing process require?”
For HVAC, cleanroom and engineering companies, that distinction matters.
Because the opportunity starts well before the tender.
It starts when the facility is being designed.
The next generation of pharma manufacturing in Southeast Asia will need more than new equipment.
It will need better-engineered environments.
And that is where the next HVAC opportunity is taking shape.
ARHC – ASEAN RHVAC & Cleanroom Industry Expo 2027 takes place 17–19 March 2027 at IMPACT Exhibition Centre, Bangkok, bringing together technologies across HVACR, cleanrooms, filtration, air handling, smart controls and related systems.
For companies supplying the infrastructure behind pharmaceutical manufacturing, it is a conversation worth entering early.Sources: Singapore EDB; ASEAN Investment Report 2025; Malaysia Investment Development Authority; ARHC official exhibition information.
